Vyome Holdings HIND
NASDAQ HIND
$2.03 -0.01 (-0.49%)
At close: Sep 28, 2026 · 4:00 PM EDT

Vyome Holdings (HIND) EBIT Margin (2015 - 2026)

Updated

Vyome Holdings (HIND) recorded EBIT Margin of -3200.02% in Q2 2026, down 2551.05 percentage points from -648.98% a year earlier but up 376.76 percentage points from the prior quarter.

Analysis

Vyome Holdings (HIND) EBIT Margin (2015 - 2026) Analysis & Trends

On a TTM basis, Vyome Holdings' EBIT Margin came in at -9190.20% as of Jun 30, 2026, down 8921.45 percentage points year-over-year; for FY2025, it was -3269.35%, down 2877.69 percentage points from FY2024.

  • Annual EBIT Margin has a five-year change of -3159.10 percentage points (FY2020 to FY2025).
  • Across earlier years, EBIT Margin came in at -391.66% in FY2024 (-214.39 pp), -177.26% in FY2023 (+235.11 pp), -412.38% in FY2022 (+13.23 pp) and -425.60% in FY2021 (-315.35 pp).
  • Quarterly EBIT Margin has ranged from -24761.92% in Q3 2025 to -95.61% in Q4 2023 over the past five years.
  • On a year-over-year basis, EBIT Margin has declined for five consecutive quarters, with an average year-over-year change of -4344.03 percentage points over the last eight quarters.
  • Peak year-over-year performance for EBIT Margin in the last five years was a gain of 657.26 percentage points in Q4 2022, against a drop of 24429.50 percentage points in Q3 2025 at the low end.
  • Per Business Quant, the preceding three quarters came in at -3576.78% (Q1 2026), -3707.35% (Q4 2025) and -24761.92% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 28.21%
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 37.86%
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn -3.52%
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 32.97%
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 20.57%
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 34.95%
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -133.21%
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 28.37%
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 37.40%
10 Vyome Holdings 14.25 Mn -11.86 Mn 11,658.00 -3,200.02%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -3,200.02%
Mar 31, 2026 -3,576.78%
Dec 31, 2025 -3,707.35%
Sep 30, 2025 -24,761.92%
Jun 30, 2025 -648.98%
Mar 31, 2025 -100.21%
Dec 31, 2024 -416.76%
Sep 30, 2024 -332.42%
Jun 30, 2024 -104.53%
Mar 31, 2024 -113.68%
Dec 31, 2023 -95.61%
Sep 30, 2023 -180.05%
Jun 30, 2023 -176.40%
Mar 31, 2023 -246.22%
Dec 31, 2022 -536.75%
Sep 30, 2022 -439.64%
Jun 30, 2022 -319.64%
Mar 31, 2022 -332.50%
Dec 31, 2021 -1,194.02%
Sep 30, 2021 -388.86%
API Access

Vyome Holdings EBIT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit-margin&ticker=HIND&period=max&api_key=YOUR_API_KEY